New antiarrhythmic agents. Amiodarone, aprindine, disopyramide, ethmozin, mexiletine, tocainide, verapamil

Douglas P. Zipes, Paul J. Troup

Research output: Contribution to journalArticle

194 Scopus citations


The present status, clinical experience, side effects, clinical pharmacology and electrophysiologic actions of seven new antiarrhythmic agents are reviewed. The drugs selected for comment are amiodarone, aprindine, disopyramide, ethmozin, mexiletine, tocainide and verapamil. Each drug has been shown to have clinical efficacy in suppressing cardiac arrhythmias.

Original languageEnglish (US)
Pages (from-to)1005-1024
Number of pages20
JournalThe American journal of cardiology
Issue number6
StatePublished - May 22 1978


ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this